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                     DETERMINATION OF TIROFIBAN IN SERUM USING  
                     LIQUID CHROMATOGRAPHY WITH UV DETECTION 
 
 
 
INTRODUCTION 
 
The aim of this study is to develop a specific, sensitive, rapid, and simple HPLC method with 
UV detection to study pharmacokinetics of tirofiban in serum of rats alone or in the presence 
of heparin as simultaneous therapy. Thirty six Wistar rats were used randomly assigned in 
two groups: control group (n = 18), and group with venous thrombosis experimentally 
induced by ligature of the femoral vein (n = 18). Tirofiban hydrochloride was dissolved in 
sterile saline. The i.v. bolus doses (0.6 mg kg-1; 0.8 mg kg-1; 1 mg kg-1) were injected using 
tail vein. Blood samples were taken in the presence of heparin during one hour: starting 15 
minutes after injection in the intervals of 15 minutes.  
EXPERIMENTAL 
 
Blood samples were centrifuged 5 min at 3500 rpm min-1. The serum was treated carefully, 
then methanol was added for precipitation of proteins (in ratio serum: methanol = 1:3). The 
tubes were again centrifuged 5 min at 3500 rpm min-1 and supernatant was injected into the 
HPLC column. HPLC separation was carried out at ambient temperature, using reversed-
phase LiChrospher® 100 RP-18 column (4.0 mm × 250 mm, 5 μm particle size). The 
chromatographic separation was performed by isocratic mode with of 0,1 M KH2PO4 (pH = 
5.0, adjusted with 1.0 N sodium hydroxide) and acetonitrile in the ratio of 80:20 % v/v as 
mobile phase with a flow rate of 1.0 ml min-1. UV detection was performed at 274 nm. The 
injection volume was 50 µl. Tirofiban concentration was also determined in spiked human 
and rat serum samples. System suitability was checked by evaluating different parameters 
(retention time, tailing factor, capacity factor, resolution, and selectivity).  
 
 
CONCLUSION 
 
The proposed RP-HPLC method is simple, accurate, precise, and rapid for the determination of tirofiban in serum and for monitoring its 
concentration in serum. The described method can be readily applied, without any interference from endogenous substances, to study 
pharmacokinetics of tirofiban in serum given alone or in the presence of heparin as simultaneous therapy and for therapeutic monitoring 
of levels of tirofiban in serum samples. 
RESULTS AND DISCUSSION 
  
Tailing and capacity factors were obtained as 1.17 and 2.41 for tirofiban. 
Resolution factor for the system for tirofiban and heparin was 3.90. The 
retention times of tirofiban in methanol, human and rat serum samples 
were 9.1, 9.2, and 9.16 min, respectively (Figure 1.). The variation in 
retention time of tirofiban among five replicate injections of standard 
solution in methanol, human and rat serum samples was very little, 
giving relative standard deviations (RSD%) of  0.61%, 0.93%, and 
0.82%, respectively.  The response was linear over the range of 0.03 – 
0.18 mg mL-1 in mobile phase and serum samples. The limit of detection 
(LOD) for tirofiban was 1.84, 13,8 and 14.6 μg mL-1 in methanol, spiked 
rat serum and spiked human serum, respectively (Table 1.). Plasma 
concentration-time profile obtained from the experimental group was 
significantly different from plasma concentration-time profile obtained 
from the control group.  
           
    M. Darkovska-Serafimovska 1,5,  Z. Arsova-Sarafinovska 2 ,  T. Balkanov3,  I. Gjorgoski 4,  N. Ugresic 5,   E. Janevik-Ivanovska 1 
 
   1,5. University Goce Delcev, Faculty of Medical Sciences, Krste Misirkov bb, 2000 Stip, Macedonia  
      2. Institute for Public Health of the Republic of Macedonia, 50 Divizija 6, 1000 Skopje, Macedonia 
      3. University Ss. Cyril and Methodius, Faculty of Medicine, 50 Divizija 6, 1000 Skopje, Macedonia 
      4. University Ss. Cyril and Methodius, Faculty of Natural Sciences and Mathematics, Gazi Baba bb,   1000  Skopje, Macedonia 
      5. University of Belgrade, Faculty of Pharmacy, Vojvode Stepe 450, 11221 Belgrade, Serbia 
            
          Characteristics of the linear regression analysis of tirofiban 
Chromatogram of standard solution of  tirofiban and heparin 
 in methanol (a) and chromatogram of serum spiked with  
 tirofiban and heparin (b) 
